drugset / Trial / NCT03893175

Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction

NCT03893175

Phase 1 Completed 86 enrolled University of Pennsylvania
RandomizedParallel-groupQuadruple-blindOther

Summary

This research study will evaluate inter-individual variability in the analgesic response to the non-steroidal anti-inflammatory drug (NSAID) ibuprofen after third molar extraction surgery. It will also investigate demographic, clinical, genetic, and environmental factors that cause this variability.

Timeline

Start
2019-05-10
Primary completion
2022-03-02
Completion
2022-03-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg Oral
Background Acetaminophen Small molecule 500 mg Oral
Background Oxycodone Other / unclassified 5 mg Oral